ad image

Company Info

WuXi AppTec

WuXi AppTec

CDMO / Preclinical CRO

Overview

WuXi AppTec is a global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform providing a range of services across the full spectrum of drug development R&D. With operations in China and the United States, WuXi AppTec has enhanced its integrated offering from an initial focus on discovery chemistry to a full range of services and solutions that support customers from discovery through commercialization. Under the WuXi AppTec corporate umbrella sit several interdependent business units that together support the organization’s mission to better serve its customers with accelerated timelines, lower costs and increased efficiencies in drug and medical device R&D. 
WuXi AppTec
Contributions
21 Contributions1 / 2
WuXi AppTec

WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

WuXi AppTec

PR-M11-20-040Mar 02, 2021
WuXi AppTec
Capacity Expansion

WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-the-Art Testing Laboratory

WuXi AppTec

PR-M11-20-019Nov 19, 2020
WuXi AppTec
Expanded Services

WuXi Advanced Therapies Expands Services to Include High-Quality and Cost-Effective R&D and GMP Plasmid DNA

WuXi AppTec

PR-M11-20-011Nov 12, 2020
WuXi AppTec
Strategic Partnership

TrakCel Announces Strategic Partnership with WuXi AppTec Advanced Therapies for Optimization of Supply Chain for Cell and Gene Therapy Treatments

WuXi AppTec

PR-M10-19-NI-008-2078Oct 01, 2019
WuXi AppTec
M&A

WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development

WuXi AppTec

PR-M05-19-NI-030May 10, 2019
WuXi AppTec
Healthcare

The First WuXi Healthcare Forum Opens in Shanghai

WuXi AppTec

PR-M03-19-NI-019Mar 06, 2019
WuXi AppTec
Awards

WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan

WuXi AppTec

PR-M12-18-NI-008Dec 04, 2018
WuXi AppTec
Announcement

WuXi AppTec Group and Mayo Clinic Receive 2018 MedTech Insight Award for Best Alliance

WuXi AppTec

PR-M10-18-NI-029Oct 09, 2018
WuXi AppTec
Artificial Intelligence

WuXi AppTec Research Service Division and Cyclica Collaborate to Drive Polypharmacology in Drug Discovery Through AI-Augmented Technologies

WuXi AppTec

PR-M09-18-NI-054Sep 19, 2018
WuXi AppTec
FDA Inspection

WuXi STA’s Jinshan Site Passes Fourth U.S. FDA Inspection

WuXi AppTec

PR-M08-18-NI-013Aug 03, 2018
WuXi AppTec
Drug Approval

WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot

WuXi AppTec

PR-M06-18-NI-057Jun 18, 2018
WuXi AppTec
Artificial Intelligence

WuXi AppTec Leads Strategic Investment in Insilico Medicine to Accelerate Drug Discovery Using Next-Generation Artificial Intelligence

WuXi AppTec

PR-M06-18-NI-037Jun 12, 2018
WuXi Laboratory Testing Division: Propelling Innovation and Better Treatments for Patients
Novel Medicine

WuXi Laboratory Testing Division: Propelling Innovation and Better Treatments for Patients

WuXi AppTec

PAO-M05-18-CL-004May 25, 2018
WuXi AppTec
IPO

WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange

WuXi AppTec

PR-M05-18-NI-037May 08, 2018
WuXi AppTec
Expanded Capacity

WuXi STA to Build a New R&D Center in Shanghai

WuXi AppTec

PR-M05-18-NI-001May 01, 2018
WuXi AppTec
Expanded Capacity

WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services

WuXi AppTec

PR-M04-18-NI-75Apr 19, 2018
WuXi AppTec
Partnership

Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec to Manufacture Universal Donor Cell Therapies

WuXi AppTec

PR-M03-18-NI-090Mar 26, 2018
Creating Comprehensive Solutions through Laboratory Testing
Laboratory Testing

Creating Comprehensive Solutions through Laboratory Testing

Xin Zhang, Ph.D.

WuXi AppTec

PAP-Q1-18-CL-011Mar 12, 2018
WuXi AppTec
Strategic Collaboration

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

WuXi AppTec

PR-M02-18-NI-93Feb 26, 2018
WuXi AppTec
Launch

WuXi AppTec Launches Advanced Library Compound Initiative on LabNetwork.com

WuXi AppTec

PR-M02-18-NI-039Feb 12, 2018
1 / 2